Ligand profile
ZINC14824920
Virtual-screening candidate from ZINC.
Bound to: VK055_0502 — tyrosine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC14824920- UniProt (similar protein)
P0AGJ9- Tanimoto
- 1.000
- Target protein
- VK055_0502
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 126.9
- −1 ≤ LogP ≤ 5 -0.18
- MW ≤ 500 Da 261.3
- LogP ≤ 5 -0.18
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 126.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N[C@H](Cc1ccc(OS(=O)(=O)O)cc1)C(=O)ON[C@H](Cc1ccc(OS(=O)(=O)O)cc1)C(=O)O
InChI=1S/C9H11NO6S/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H,13,14,15)/t8-/m1/s1InChI=1S/C9H11NO6S/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H,13,14,15)/t8-/m1/s1
CIQHWLTYGMYQQR-MRVPVSSYSA-NCIQHWLTYGMYQQR-MRVPVSSYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- TYS
- Homolog
- P0AGJ9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC14824920 →
- ZINC ZINC20 ZINC14824920 →
- UniProt UniProt P0AGJ9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC14824920”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0502.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 7
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).